Down syndrome (DS) is one of the prevalent chromosomal disorders, representing distinctive craniofacial features and a range of developmental and medical challenges. Due to the lack of clinical expertise and high infrastructure costs, access to genetic testing is restricted to resource-constrained clinical settings. There is a demand for developing a non-invasive and equitable DS screening tool, facilitating DS diagnosis for a wide range of populations. In this study, we develop and validate a robust, interpretable deep learning model for the early detection of DS using facial images of infants. A hybrid feature extraction architecture combining RegNet X-MobileNet V3 and vision transformer (ViT)-Linformer is developed for effective feature representation. We use an adaptive attention-based feature fusion to enhance the proposed model's focus on diagnostically relevant facial regions. Bayesian optimization with hyperband (BOHB) fine-tuned extremely randomized trees (ExtraTrees) is employed to classify the features. To ensure the model's generalizability, stratified five-fold cross-validation is performed. Compared to the recent DS classification approaches, the proposed model demonstrates outstanding performance, achieving an accuracy of 99.10%, precision of 98.80%, recall of 98.87%, F1-score of 98.83%, and specificity of 98.81%, on the unseen data. The findings underscore the strengths of the proposed model as a reliable screening tool to identify DS in the early stages using the facial images. This study paves the foundation to build equitable, scalable, and trustworthy digital solution for effective pediatric care across the globe.
face imagesinfantsnon-invasive screeninghybrid feature extraction
Journal of Pain Research · مجلد Volume 18 · 1131-1142
Background: Between half and three quarters of the working-age population in today's industrialized globe suffers from lower back pain. The presence of a myofascial trigger point-a hyperirritable painful area comprised of a small number of muscle fibers-identifies mechanical back pain sufferers as suffering from myofascial pain syndrome, a chronic pain disorder. This research objectives to determine whether mechanical back pain patients' pain severity and functional disabilities are influenced by electromagnetic field therapy. Methods and Subjects: Two groups of thirty patients were randomly assigned. The 15 participants in group A underwent conventional physical therapy (including ultrasound, stretches, and strength training for the back muscles), while the 15 participants in group B received a combination of conventional physical therapy and electromagnetic field therapy. Pre- and post-treatment assessments of pain intensity, functional impairment, and lumbar range of motion (including extension, flexion, and right and left side bending) were examined. The variables of interest that were examined at various testing groups and measuring periods were compared using a 2×2 mixed design MANOVA. Results: After treatment, there was a significant difference in all dependent variables between the two groups in terms of between-subject effects (p <0.05). Group B benefited from a significant decrease in pain, right and left side bending, and function disability, as well as an increase in flexion and extension. Conclusion: Patients suffering from mechanical back pain can find relief from their discomfort and functional impairment through the use of electromagnetic field therapy, according to the current study's conclusions.
electromagnetic field therapymechanical low back painmyofascial trigger pointsmyofascial pain syndrome
Across the globe, chronic obstructive pulmonary disease (COPD) continues to be a critical healthcare burden due to its progressive and undetected decline in pulmonary function. In recent times, convolutional neural networks (CNNs) and vision transformers (ViTs) have been widely applied to lung sounds (LS) analysis, leading to the development of improved non-invasive, accessible, and scalable COPD screening methods. However, the shortcomings of CNNs and ViTs architectures restrict the COPD classifier’s discriminative power in distinguishing normal and COPD samples. In this study, a unique and interpretable COPD classification is proposed. This study introduces a hybrid feature extraction strategy integrating CNNs and ViTs architecture to capture the crucial COPD patterns from the LS’s Mel-spectrogram representation. The proposed CNNs-ViTs architecture addresses the limitations of standalone CNNs or ViTs architectures by capturing fine-grained acoustic features and long-range temporal dependencies while efficiently modeling non-linear relationships. A novel feature fusion is used to combine the heterogeneous features into a unified and highly discriminative feature representation space. A tailored hyperparameter optimization strategy is developed to fine-tune the Kolmogorov-Arnold Networks (KANs) for classifying the features into normal and COPD classes. By incorporating internal (552 Healthy and 1324 COPD LS recordings) and external (35 Healthy and 77 COPD LS recordings) datasets, the authors evaluate the model’s performance. The model achieves a generalization accuracy of 97.62% and specificity of 96.51% on the external dataset. Through Shapley Additive Explanations (SHAP) overlays, the model’s interpretability is enhanced. The experimental findings highlight the effectiveness of the proposed COPD classification architecture in the domain of biomedical acoustic signal processing. Operating with minimal reliance on specialized diagnostic infrastructure renders the proposed model ideal for primary care and resource-limited environments.
Advanced Health Science and Technology Journal · مجلد 1 (1) · 1-1
Welcome to the inaugural issue of the Advanced Health Science and Technology Journal (AHSTJ), a premier platform that brings together the most current and impactful research in health sciences and technology. It is with great pride and enthusiasm that we launch this journal, marking a significant milestone for AlMaarefa University and its commitment to advancing knowledge and innovation in the field of health care. As we embark on this exciting journey, the mission of AHSTJ is clear: to publish high-quality, peer-reviewed research that addresses the most pressing challenges and opportunities in health science and technology. In an era where the intersection of health care and technology is revolutionizing patient care, diagnostics, and treatment methods, AHSTJ aims to provide a space for cutting-edge research, groundbreaking discoveries, and thought leadership that will shape the future of the health sector. The healthcare landscape is evolving rapidly with advancements in medical technologies, artificial intelligence, telemedicine, bioinformatics, and personalized medicine. In this context, AHSTJ recognizes the importance of fostering collaboration between multidisciplinary experts, from healthcare professionals and researchers to engineers and technologists. This journal serves as a bridge that connects these diverse fields, fostering innovation, and cross-pollination of ideas. The research published in this inaugural issue reflects the breadth and depth of topics that will be explored in future volumes. From innovative medical devices to computational models and the ethical considerations in health tech, AHSTJ is dedicated to supporting and disseminating knowledge that drives positive change. The contributions from researchers and scholars across the globe provide a testament to the interdisciplinary nature of modern health sciences and technology. As we look to the future, AHSTJ is poised to become a vital resource for those at the forefront of medical research, healthcare delivery, and technology development. We invite readers, practitioners, researchers, and students to engage with the journal, share their insights, and contribute to the growing body of knowledge that will ultimately improve health outcomes worldwide. On behalf of the editorial team, we thank our contributors, reviewers, and readers for their support. We are excited to be part of this remarkable journey and look forward to the continued success of the AHSTJ.
health scienceshealth technologymedical devicesartificial intelligence in healthcare
Journal of Biomolecular Structure and Dynamics · مجلد 44 (4) · 1696-1705
Around four years have passed since the globe was shaken by the COVID-19 pandemic, triggered by SARS-CoV-2, affecting almost one billion individuals worldwide and claiming the lives of millions. Despite stringent safety measures and the swift expansion of vaccination initiatives, managing waves of illness has proven challenging. Given its crucial involvement in replication and notable conservation, our team persisted in focusing on the SARS-CoV-2 main protease enzyme (Mpro) as a highly promising therapeutic objective. Accordingly, a multistep computer-aided drug discovery process was used in this study to elucidate potential lead candidates targeting SARS-CoV-2 Mpro. A protein-ligand interaction fingerprint (PLIF) tool was utilized to help design a structure-based pharmacophore based on critical interactions between known ligands and the Mpro active site. The produced pharmacophore was used to filter a fraction of the ZINC database of chemical substances, resulting in 703 possible hits. All the filtered compounds achieved acceptable docking scores and four compounds achieved higher docking scores of selected Mpro inhibitor reference, and the top-ranked compound W1 (ZINC000150656136) was selected for more simulations. A combination of traditional molecular dynamics (MD) and MM-PBSA was used in the final step. W1 has been predicted to engage with multiple essential interactions with key residues in the Mpro active with a docking score and binding free energy of 11.1 kcal/mol and −324.7 ± 9.7 Kj/mol, respectively. As a result, we propose W1 as a lead compound candidate towards the SARS-CoV-2 Mpro enzyme that can be forwarded for experimental validation and clinical studies for COVID-19 management.
SARS-CoV-2main proteaseMpro inhibitorsCOVID-19 drug discovery
Abstract Cardiovascular disease (CD) is one of the leading causes of death and disability across the globe. Chest x‐rays (CXR) are crucial in detecting chest and CD. The CXR images present helpful information to the radiologist to identify a disease at an earlier stage. Several convolutional neural network (CNN) models for classifying the CXR images have been established. However, there is a demand for significant improvement in CNN models to generalize them in diverse datasets. In addition, healthcare centers require an effective model for identifying CD with limited resources. Therefore, the authors developed a CNN‐based CD detector using CXR images. The proposed research employs the You Only Look Once, version 7 technique to extract features and DenseNet‐161 for classifying the CXR images into normal and abnormal classes. The authors utilized datasets, including CheXpert and VinDr‐CXR, for the performance evaluation. The findings reveal that the proposed study achieves an accuracy and F1‐measure of 97.9, 97.47, 96.85, and 97.77 for the CheXpert and VinDr‐CXR datasets, respectively. The recommended model required fewer parameters of 5.2 M and less computation time for predicting CD. The study's outcome can assist clinicians in detecting CD at the earliest stage.
Lumpy skin disease is a fatal emerging disease of cattle, which has started to gain extensive attention due to its rapid incursions across the globe. The disease epidemic causes economic loss and cattle morbidity. Currently, there are no specific treatments and safe vaccines against the lumpy skin disease virus (LSDV) to halt the spread of the disease. The current study uses genome-scan vaccinomics analyses to prioritize promiscuous vaccine candidate proteins of the LSDV. These proteins were subjected to top-ranked B- and T-cell epitope prediction based on their antigenicity, allergenicity, and toxicity values. The shortlisted epitopes were connected using appropriate linkers and adjuvant sequences to design multi-epitope vaccine constructs. Three vaccine constructs were prioritized based on their immunological and physicochemical properties. The model constructs were back-translated to nucleotide sequences and codons were optimized. The Kozak sequence with a start codon along with MITD, tPA, Goblin 5', 3' UTRs, and a poly(A) tail sequences were added to design a stable and highly immunogenic mRNA vaccine. Molecular docking followed by MD simulation analysis predicted significant binding affinity and stability of LSDV-V2 construct within bovine immune receptors and predicted it to be the top-ranked candidate to stimulate the humeral and cellular immunogenic responses. Furthermore, in silico restriction cloning predicted feasible gene expression of the LSDV-V2 construct in a bacterial expression vector. It could prove worthwhile to validate the predicted vaccine models experimentally and clinically against LSDV.
Coronary artery disease (CAD) is one of the major causes of fatalities across the globe. The recent developments in convolutional neural networks (CNN) allow researchers to detect CAD from computed tomography (CT) images. The CAD detection model assists physicians in identifying cardiac disease at earlier stages. The recent CAD detection models demand a high computational cost and a more significant number of images. Therefore, this study intends to develop a CNN-based CAD detection model. The researchers apply an image enhancement technique to improve the CT image quality. The authors employed You look only once (YOLO) V7 for extracting the features. Aquila optimization is used for optimizing the hyperparameters of the UNet++ model to predict CAD. The proposed feature extraction technique and hyperparameter tuning approach reduces the computational costs and improves the performance of the UNet++ model. Two datasets are utilized for evaluating the performance of the proposed CAD detection model. The experimental outcomes suggest that the proposed method achieves an accuracy, recall, precision, F1-score, Matthews correlation coefficient, and Kappa of 99.4, 98.5, 98.65, 98.6, 95.35, and 95 and 99.5, 98.95, 98.95, 98.95, 96.35, and 96.25 for datasets 1 and 2, respectively. In addition, the proposed model outperforms the recent techniques by obtaining the area under the receiver operating characteristic and precision-recall curve of 0.97 and 0.95, and 0.96 and 0.94 for datasets 1 and 2, respectively. Moreover, the proposed model obtained a better confidence interval and standard deviation of [98.64-98.72] and 0.0014, and [97.41-97.49] and 0.0019 for datasets 1 and 2, respectively. The study's findings suggest that the proposed model can support physicians in identifying CAD with limited resources.
Background: Every year World Diabetes Day (WDD) is celebrated on 14November all across the globe to raise awareness about the diabetes and its prevention, complications and treatment.Complications include macrovascular conditions, such as coronary heart disease, stroke and microvascular, including diabetic nephropathy, retinopathy and peripheral neuropathy.We aim to assess the relationship between random glucose blood glucose and chronic diseases.Methods: A cross-sectional study in Riyadh on November 2021 and January 2022 at a public shopping center.Data collection sheet was prepared for age, weight, gender, hypertension, diabetes mellitus, ischemic heart disease, random blood glucose and Glucometer devices were used to gather the data.One of the volunteers took a visitor's random blood glucose reading and weight in kilograms using a mechanical scale.Data analyzed using SPSS.Result: Majority of participants was male (54%) with age group from 30-39 years old (29.3%) with weight in kilo gram from 60-79 (43.4%).Prevalence of diabetes was (18%) and hypertension (17%) and ischemic heart disease (1.8%).Relation between age and RBG (p value= 0.000) and between weight and RBG (p value=0.243).Conclusion: According to this study, Saudi Arabia is one of the average countries in terms of the number of diabetic patients.High prevalence of diabetics, especially men in the 30-to 39year-old age group who weight between 60 and 79 kg.Almost majority of the patients had hypertension in addition to diabetes.The statistical relationship between age and random blood glucose was significant.
Lung cancer is the dominant emerging factor in cancer-related mortality around the globe. Therapeutic interventions for lung cancer are not up to par, mainly due to reoccurrence/relapse, chemoresistance, and late diagnosis. People are currently interested in miRNAs, which are small double-stranded (20-24 ribonucleotides) structures that regulate molecular targets (tumor suppressors, oncogenes) involved in tumorigeneses such as cell proliferation, apoptosis, metastasis, and angiogenesis via post-transcriptional regulation of mRNA. Many studies suggest the emerging role of miRNAs in lung cancer diagnostics, prognostics, and therapeutics. Therefore, it is necessary to intensely explore the miRNOME expression of lung tumors and the development of anti-cancer strategies. The current review focuses on the therapeutic, diagnostic, and prognostic potential of numerous miRNAs in lung cancer.
Frontiers in Pharmacology · مجلد 13 · 879118-879118
Beginning from December 2019, widespread COVID-19 has caused huge financial misfortunes and exceptional wellbeing emergencies across the globe. Discovering an effective and safe drug candidate for the treatment of COVID-19 and its associated symptoms became an urgent global demand, especially due to restricted information that has been discharged with respect to vaccine efficacy and safety in humans. Reviewing the recent research, olive leaves were selected as a potential co-therapy supplement for the treatment and improvement of clinical manifestations in COVID-19 patients. Olive leaves were reported to be rich in phenolic compounds such as oleuropein, hydroxytyrosol, verbascoside, apigenin-7-O-glucoside, and luteolin-7-O-glucoside and also triterpenoids such as maslinic, ursolic, and oleanolic acids that have been reported as anti–SARS-CoV-2 metabolites in recent computational and in vitro studies. In addition, olive leaf extract was previously reported in several in vivo studies for its anti-inflammatory, analgesic, antipyretic, immunomodulatory, and antithrombotic activities which are of great benefit in the control of associated inflammatory cytokine storm and disseminated intravascular coagulation in COVID-19 patients. In conclusion, the described biological activities of olive leaves alongside their biosafety, availability, and low price make them a potential candidate drug or supplement to control COVID-19 infection and are recommended for clinical investigation.
olive leavesCOVID-19 pandemicSARS-CoV-2herbal medicine
BACKGROUND: Self-medication (SM) is a customary practice around the globe. Appropriate SM comes with many advantages, yet irrational SM is a concern and could lead to adverse drug events and poor health outcomes. METHODS: This college-based cross-sectional study was carried out from January to March 2021 among Najran University undergraduate medical students to investigate the prevalence and practice of, and attitudes towards SM. Data were collected using a bilingual self-administered online questionnaire, which was categorized into sections, such as socio-demographic details, attitude towards SM, and practice of SM during the last six months, along with students' opinions and suggestions regarding SM. The three-item scale was used to assess the students' attitude. IBM SPSS was used to perform the cross-tabulation, chi-squared test, and binary logistic regression. RESULTS: Overall, 205 undergraduate medical students (58.6%) responded to the survey. The overall prevalence of SM was 60%, of which 25% used antibiotics as SM drugs. Headache (65.9%), fever (30.2%), cold/flu (31.2%), and gastric acidity (28.3%) were common illnesses for which SM was sought, using analgesics and NSAIDs (52.7%), antipyretics (13.7%), and antacid (12.7%) medications. Among the reasons for SM, the illness being minor and quick relief were frequently reported. To rationalize and improve the practice of SM, about half (48.3%) of the students suggested spreading awareness and education regarding the implications of SM and dispensing the medications with prescriptions (46.8%). CONCLUSION: Overall, the attitude towards SM was satisfactory. The prevalence of SM during the last six months was 60%, and antibiotics were used by 25% of students. A significant negative correlation was observed between attitudes towards and practice of SM. Although medical students of Najran University displayed responsible behavior towards SM, efforts should be made to educate them about the adverse consequences of SM, especially with antibiotics.
self-medicationmedical studentsantibiotic self-medicationirrational drug use
Journal of Environmental Pathology Toxicology and Oncology · مجلد 41 (4) · 85-102
Lung cancer is the leading cause of cancer-related mortality across the globe. The most prevalent pathological form of lung cancer is non-small-cell lung cancer (NSCLC). Elevated stimulation of the PI3K/Akt/mTOR pathway causes a slew of cancer-related symptoms, making it a promising target for new anticancer drugs. The PI3K/Akt/mTOR path is involved extensively in carcinogenesis and disease advancement in NSCLC. Several new inhibitors targeting this pathway have been discovered in preclinical investigations and clinical trials. The etiology and epidemiology of NSCLC and biology of the PI3K/Akt/mTOR cascade and its role in NSCLC pathogenesis have all been discussed in this article. In this article, we've reviewed PI3K/Akt/mTOR cascade inhibitors that have been proven in vitro and in preclinical trials to be effective in NSCLC. Drugs targeting the PI3K/Akt/mTOR path in the treatment of NSCLC were also addressed. A better knowledge of the underlying molecular biology, including epigenetic changes, is also critical to detecting relevant biomarkers and guiding combination methods. Additionally, improved clinical trial designs will increase the capacity to test novel drugs and combinations for accounting for genomic variation and eventually improve patient outcomes.
Background: Acinetobacter baumannii is an opportunistic pathogen associated with healthcare infections and high mortality rates in intensive care units all over the globe. Porins and efflux pumps over-expression have been reported as contributing factors in escalating drug resistance and rendering treatment ineffective. In this study, we investigated the mechanisms of multidrug resistance (MDR) in A. baumannii clinical isolates. Methods: A total of 30 A. baumannii isolates were included in the present study from Nehru Hospital (PGIMER-Chandigarh) located in North India. Kirby Bauer disk diffusion assay and MIC were performed to determine the antimicrobial susceptibility pattern. Screening of beta-lactamases was performed using PCR. Relative gene expression of four RND, one MATE efflux pump, and two outer membrane proteins were determined using RT-PCR. Molecular typing of 22 isolates was carried out using MLST Oxford scheme. Results: CarO porin genes showed over-expression in 63% isolates followed by adeGandabeM efflux pump downregulation/underexpression (<0.5 fold), suggesting the carbapenem-susceptible phenotypic nature of the isolates. High prevalence of VIM-2, NDM-1, and OXA-23 genes was observed in A. baumannii isolates. Interestingly, NDM-1 and OXA-58 were traced in 10 and3 A. baumannii isolates respectively; 13 of 22 (59%) isolates showed novel Sequence Types (STs) in the Multi-Locus Sequence Typing (MLST) analysis. ST 1087 was most commonly found ST among all others (16 STs). Conclusions: This study indicated a possible role of carO porin genes and adeG (RND) andabeM (MATE) efflux pumps in carbapenem susceptibility of A. baumannii. New STs were also reported in the majority of the isolates.
Human Vaccines & Immunotherapeutics · مجلد 18 (1) · 2031455-2031455
A qualitative exploration of pharmacists’ perceptions regarding COVID-19 conspiracies and their willingness to get vaccinated. A semi-structured questionnaire guide was developed using ground theory to conduct in-depth interviews. A total of 36 participants gave consent for an audio-recorded interview. Results have shown that most of the respondents believed that SARS-CoV-2 is a natural virus, not man-made, that causes a disease just like other viruses and it is absurd to believe that the vaccine is being used by foreign powers for the implantation of microchips just to control humans. A general opinion thatwhich reflected from the in-depth interview is that the pharmaceutical companies may be hiding some important information on COVID-19 to promote the sale of their product. Some doubts on the reliability and trustworthiness on the COVID-19 vaccine safety and efficacy data were noticed among the respondents. Factors leading to COVID-19 vaccine hesitancy were adverse reaction, cost of COVID-19 vaccine, and limited data on safety and efficacy profile of COVID-19 vaccine. COVID-19 vaccine hesitancy among health professionals is a major hindrance to our current fight against COVID-19 pandemic. Findings of this study are alarming, and the stakeholders must consider this ongoing vaccination campaign as an opportunity to formulate a mechanism to ensure high vaccination rate among general public and healthcare providers in Pakistan.KEY POINTSWhat was already known?According to World Health Organization (WHO), vaccine hesitancy is one of the ten major threats to global healthcare system and it is a major barrier to achieve herd immunity around the globe.Pakistan has begun vaccinating its people in a systematic phase-wise manner under which the healthcare workers and elderly people are prioritized for vaccination.Previous experience tells us that vaccine hesitancy is a major problem in Pakistan and it is better to understand perceptions of pharmacists about COVID-19 vaccine who are the primary source of information for most of general population.What this study adds:This study is first of its kind to explore vaccine hesitancy among Pakistani pharmacists and the results of this study show that majority of the participants were willing to get COVID-19 vaccine and few of them have even got themselves vaccinated at the start of vaccination campaign.Many among the willing participants considered cost of vaccine, adverse reactions, limited data, safety, and efficacy as major hindrance to their decision to get vaccine.Few participants were found highly vaccine-hesitant because of their staunch belief in the prevalent myths and rumors about COVID-19 vaccine.